Skip to Main Content

Author Details

Max Schwarz
Central Clinical School, Monash University
2006
20
10
PMIDPaper TitleJournal TitlePublished Year
23735033Intended follow up of women with breast cancer at low risk of recurrence and at least 5 years from diagnosis.Intern Med J2014
23975613Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment.J Cancer Surviv2014
24495702A comparison of the characteristics, treatment and outcome after 5 years, of Australian women aged 70+ with those aged <70 years at the time of diagnosis of breast cancer.J Geriatr Oncol2014
23735033Intended follow up of women with breast cancer at low risk of recurrence and at least 5 years from diagnosis.Intern Med J2014
24495702A comparison of the characteristics, treatment and outcome after 5 years, of Australian women aged 70+ with those aged <70 years at the time of diagnosis of breast cancer.J Geriatr Oncol2014
23975613Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment.J Cancer Surviv2014
22985255Use of imaging in surveillance of women with early stage breast cancer.ANZ J Surg2013
22948136Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis.Menopause2013
22985255Use of imaging in surveillance of women with early stage breast cancer.ANZ J Surg2013
23793165Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis.Menopause2013
23791664Pregnancy-associated breast cancer and pregnancy following treatment for breast cancer, in a cohort of women from Victoria, Australia, with a first diagnosis of invasive breast cancer.Breast2013
23435596Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia.Support Care Cancer2013
23793165Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis.Menopause2013
23791664Pregnancy-associated breast cancer and pregnancy following treatment for breast cancer, in a cohort of women from Victoria, Australia, with a first diagnosis of invasive breast cancer.Breast2013
23435596Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia.Support Care Cancer2013
22948136Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis.Menopause2013
21479524Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: a cohort study of women from Victoria, Australia.Support Care Cancer2012
22595247Breast reconstruction following mastectomy for invasive breast cancer is strongly influenced by demographic factors in women in Victoria, Australia.Breast2012
21479524Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: a cohort study of women from Victoria, Australia.Support Care Cancer2012
22595247Breast reconstruction following mastectomy for invasive breast cancer is strongly influenced by demographic factors in women in Victoria, Australia.Breast2012
21332650An exploration of the dynamics and influences upon second medical opinion consultations in cancer care.Asia Pac J Clin Oncol2011
21332650An exploration of the dynamics and influences upon second medical opinion consultations in cancer care.Asia Pac J Clin Oncol2011
19802635Second medical opinions: the views of oncology patients and their physicians.Support Care Cancer2010
19707799Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis.Support Care Cancer2010
19802635Second medical opinions: the views of oncology patients and their physicians.Support Care Cancer2010
20505545Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer.Menopause2010
21761352The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics.Horm Cancer2010
21761352The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics.Horm Cancer2010
20505545Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer.Menopause2010
19707799Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis.Support Care Cancer2010
19221894The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer.Fam Cancer2009
19221894The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer.Fam Cancer2009
19538800Patients' views on decision making in advanced cancer.Palliat Support Care2009
20044859Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancer.J Womens Health (Larchmt)2009
20044859Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancer.J Womens Health (Larchmt)2009
19538800Patients' views on decision making in advanced cancer.Palliat Support Care2009
17199844Anger in palliative care: a clinical approach.Intern Med J2007
17199844Anger in palliative care: a clinical approach.Intern Med J2007
16637811Multiple periungual pyogenic granulomas following systemic 5-fluorouracil.Australas J Dermatol2006
16637811Multiple periungual pyogenic granulomas following systemic 5-fluorouracil.Australas J Dermatol2006
  • 1 - 40 of 40

Recommended Authors

University of Leeds
Career Start Year 2015
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 2007
Number of shared co-authors 0
The Ottawa Hospital Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Columbia University Irving Medical Center
Career Start Year 2004
Number of shared co-authors 0
University of Washington
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 0
CHU de Quebec-Universite Laval Research Center
Career Start Year 1998
Number of shared co-authors 0
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 0
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Career Start Year 1998
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 0
Mayo Clinic Health System
Career Start Year 1997
Number of shared co-authors 0
Odette Cancer Centre
Career Start Year 1996
Number of shared co-authors 0
Department of Medicine and Moores Cancer Center, University of California San Diego.
Career Start Year 1994
Number of shared co-authors 0
University of California los angeles
Career Start Year 1994
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Institute of Cancer and Genomic Sciences, The University of Birmingham
Career Start Year 1993
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
and Clinical Research Center, Morehouse School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
Warwick Clinical Trials Unit, University of Warwick
Career Start Year 1991
Number of shared co-authors 0
College of Nursing, University of South Florida
Career Start Year 1991
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 1990
Number of shared co-authors 0
National and Kapodistrian University of Athens
Career Start Year 1987
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 0
University of Toronto, University Health Network
Career Start Year 1984
Number of shared co-authors 0
School of Public Health, University of Michigan ann arbor
Career Start Year 1973
Number of shared co-authors 0

Collaborators

School of Public Health and Preventive Medicine, Monash University
Co-authored papers 15
School of Public Health and Preventive Medicine, Monash University
Co-authored papers 15
Co-authored papers 15
Co-authored papers 14
School of Public Health and Preventive Medicine, Monash University
Co-authored papers 7
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1